الفهرس 
DESCRIPTION OF THE CONDITIONOnly 14 pages are availabe for public view
 |  | from | 58 |  |  |
| | | from | 58 | | |
Abstract
Leg telangiectasias and reticular veins are a common complaint affecting more than 80% of the population to some extent. Telangiectasias, reticular veins and varicose veins are the visible signs of chronic venous disease, and can occur in the presence or absence of either symptoms or an underlying functional venous disorder (reflux).
The included studies evaluated a number of sclerosing agents, types of exo-laser or combination between two modalities used in the treatment of telangiectasias, spider veins and reticular veins of the lower limbs. Asymptomatic patients with telangiectasias or reticular veins often find the cosmetic appearance of their veins distressing.
Sclerotherapy and laser have similar effectiveness with a good safety profile. Laser treatment is more painful than sclerotherapy, while the latter lead to a faster clearing of the vessels but an increased rate of post-inflammatory hyperpigmentation. Furthermore, the patient’s satisfaction was similar in the two modalites. Nevertheless, the best results seemed to be achieved when sclerotherapy is first used followed by a laser treatment. Sclerotherapy is able to treat not only telangiectasias but also the feeder veins in the same session. In contrast patients with allergy to sclerosants or fear of needles represent good candidates for laser therapy.
There is currently no evidence suggesting superior efficacy or increased patient satisfaction with any one sclerosant or laser type. Better results seemed to be achieved when sclerotherapy is first used followed by a laser treatment.